These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2853074)

  • 21. Differential regulation of subtypes m1-m5 of muscarinic receptors in forebrain by chronic atropine administration.
    Wall SJ; Yasuda RP; Li M; Ciesla W; Wolfe BB
    J Pharmacol Exp Ther; 1992 Aug; 262(2):584-8. PubMed ID: 1323653
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence for the coupling of muscarinic M1 receptors to polyphosphoinositide turnover in rat cortical synaptosomes.
    Wei JW; Hung WC
    Chin J Physiol; 1989; 32(2):103-14. PubMed ID: 2561651
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interaction of psychotropic drugs with brain muscarinic cholinoceptors: similarities of biperiden with pirenzepine in receptor binding properties.
    Syvälahti EK; Laurén L; Markkanen J; Kunelius R
    Pharmacol Toxicol; 1987 Jan; 60(1):66-9. PubMed ID: 3562393
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Muscarinic M2 receptor-mediated cyclic AMP reduction in mechanically dissociated rat cortex.
    Anderson DJ; McKinney M
    Brain Res; 1988 Dec; 475(1):28-34. PubMed ID: 2850835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional and direct binding studies using subtype selective muscarinic receptor antagonists.
    Kunysz EL; Michel AD; Whiting RL
    Br J Pharmacol; 1988 Mar; 93(3):491-500. PubMed ID: 2897216
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rat hippocampal muscarinic autoreceptors are similar to the M2 (cardiac) subtype: comparison with hippocampal M1, atrial M2 and ileal M3 receptors.
    Richards MH
    Br J Pharmacol; 1990 Apr; 99(4):753-61. PubMed ID: 1694463
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term atropine treatment lowers the efficacy of carbachol to stimulate phosphatidylinositol breakdown in the cerebral cortex and hippocampus of rats.
    Goobar L; Bartfai T
    Biochem J; 1988 Mar; 250(3):727-34. PubMed ID: 3390140
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of the subtype of muscarinic receptor coupled to the stimulation of phosphoinositide hydrolysis in 132-1N1 human astrocytoma cells.
    Stephan CC; Sastry BV
    Cell Mol Biol (Noisy-le-grand); 1992 Nov; 38(7):701-12. PubMed ID: 1282058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chimeric m2/m3 muscarinic receptors: role of carboxyl terminal receptor domains in selectivity of ligand binding and coupling to phosphoinositide hydrolysis.
    Wess J; Bonner TI; Brann MR
    Mol Pharmacol; 1990 Dec; 38(6):872-7. PubMed ID: 2174507
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Muscarinic receptor-mediated phosphoinositide hydrolysis in the rat retina.
    Moroi-Fetters SE; Neff NH; Hadjiconstantinou M
    J Pharmacol Exp Ther; 1988 Aug; 246(2):553-7. PubMed ID: 2841451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Muscarinic receptor coupling to inositol phospholipid metabolism in guinea-pig cerebral cortex, parotid gland and ileal smooth muscle.
    Ek B; Nahorski S
    Biochem Pharmacol; 1988 Dec; 37(23):4461-7. PubMed ID: 2849446
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional role for the M2 muscarinic receptor in smooth muscle of guinea pig ileum.
    Thomas EA; Baker SA; Ehlert FJ
    Mol Pharmacol; 1993 Jul; 44(1):102-10. PubMed ID: 8393516
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Competitive inhibition of phosphoinositide hydrolysis by the muscarinic receptor antagonist AF-DX 116 is of low affinity in mouse cerebral cortex.
    Smith TL; Yamamura HI
    Brain Res; 1987 Sep; 420(2):362-4. PubMed ID: 3676767
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Muscarinic receptor heterogeneity in rat central nervous system. II. Brain receptors labeled by [3H]oxotremorine-M correspond to heterogeneous M2 receptors with very high affinity for agonists.
    Gillard M; Waelbroeck M; Christophe J
    Mol Pharmacol; 1987 Jul; 32(1):100-8. PubMed ID: 3600611
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Muscarinic cholinergic receptor subtypes in the human brain. II. Quantitative autoradiographic studies.
    Cortés R; Probst A; Tobler HJ; Palacios JM
    Brain Res; 1986 Jan; 362(2):239-53. PubMed ID: 3753655
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pseudo-noncompetitive antagonism of muscarinic receptor-mediated cyclic GMP formation and phosphoinositide hydrolysis by pirenzepine.
    el-Fakahany EE; Surichamorn W; Amrhein CL; Stenstrom S; Cioffi CL; Richelson E; McKinney M
    J Pharmacol Exp Ther; 1988 Dec; 247(3):934-40. PubMed ID: 2849677
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of muscarinic receptor subtypes and their responsiveness in rat brain following chronic atropine administration.
    Lee W; Wolfe BB
    Mol Pharmacol; 1989 Nov; 36(5):749-57. PubMed ID: 2555673
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological profiles for rat cortical M1 and M2 muscarinic receptors using selective antagonists: comparison with N1E-115 muscarinic receptors.
    McKinney M; Anderson DJ; Vella-Rountree L; Connolly T; Miller JH
    J Pharmacol Exp Ther; 1991 Jun; 257(3):1121-9. PubMed ID: 1646322
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of in vivo and in vitro treatments with N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline on putative muscarinic receptor subtypes in rat brain.
    Norman AB; Creese I
    Mol Pharmacol; 1986 Aug; 30(2):96-103. PubMed ID: 3755499
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heterogeneity of muscarinic receptors coupled to phosphoinositide breakdown in guinea pig brain and peripheral tissues.
    Noronha-Blob L; Lowe VC; Hanson RC; U'Prichard DC
    Life Sci; 1987 Aug; 41(8):967-75. PubMed ID: 3039279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.